Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
With a market cap of 1.02T, Eli Lilly(LLY) trades at $1,097.43. The stock has a price-to-earnings ratio of 38.83 and currently yields dividends of 59.9%.
On 2026-06-04, Eli Lilly(LLY) stock moved within a range of $1,078.78 to $1,100.00. With shares now at $1,097.43, the stock is trading +1.7% above its intraday low and -0.2% below the session's peak.
Trading activity shows a volume of 18.87K, compared to an average daily volume of 3.29M.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,149.10 and a low of $623.78.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,149.10 and a low of $623.78.
LLY News
Key Points Eli Lilly has worked hard to diversify its pipeline. Three new acquisitions will further help decrease its exposure to its core market. Eli Lilly'...
Sen. Elizabeth Warren (D-Mass.) criticized President Donald Trump’s trading activity, arguing that the volume and timing of transactions in his investment portf...
Key Points Eli Lilly's retatrutide seems even more effective than Zepbound. The drugmaker should continue riding the weight-loss tailwind. 10 stocks we like...
Analyst ratings
85%
of 33 ratingsMore LLY News
Eli Lilly (LLY) CEO Dave Ricks told German business daily Handelsblatt that his company will halve its initially planned €2.3B ($2.7B) investment in Germany as...
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Unlock trusted, data-backed investing tools with TipRanks Premium, from analys...
The analyst who called NVIDIA in 2010 just named his top 10 stocks and Eli Lilly wasn't one of them. Get them here FREE . Over recent months, a striking patter...
Eli Lilly’s (LLY) top dealmaker says that the pharmaceutical giant is likely to undertake more acquisitions as it pushes into new medicinal areas. Unlock trust...
Eli Lilly and Ascidian Therapeutics to research and develop kidney-disease treatments. mike segar / Reuters Eli Lilly LLY -1.67 %decrease; red down pointing tr...
Key Points Eli Lilly's Jacob Van Naarden says Lilly is using the financial strength from its GLP-1 drugs like Mounjaro and Zepbound to fund its new dealmaking s...
Key Points Eli Lilly just posted encouraging results from a clinical trial for a gene-editing candidate. It could compete with CRISPR Therapeutics, a gene edi...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.